Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.44 USD 0.88% Market Closed
Market Cap: 39.4m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note

Collplant Biotechnologies Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Collplant Biotechnologies Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cost of Revenue
-$1.1m
CAGR 3-Years
28%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cost of Revenue
-$91m
CAGR 3-Years
-19%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cost of Revenue
-$8.7m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cost of Revenue
-$90k
CAGR 3-Years
33%
CAGR 5-Years
2%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
39.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price

See Also

What is Collplant Biotechnologies Ltd's Cost of Revenue?
Cost of Revenue
-1.1m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Cost of Revenue amounts to -1.1m USD.

What is Collplant Biotechnologies Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
7%

Over the last year, the Cost of Revenue growth was -1 025%. The average annual Cost of Revenue growth rates for Collplant Biotechnologies Ltd have been 28% over the past three years , 7% over the past five years .

Back to Top